Michael Cola
Chairman presso PHATHOM PHARMACEUTICALS, INC.
Patrimonio netto: 199 635 $ in data 31/03/2024
Profilo
Michael F.
Cola is currently the Chairman-Governors Board at The Boys & Girls Clubs of Philadelphia, Chairman at Phathom Pharmaceuticals, Inc., Independent Director at SAGE Therapeutics, Inc., and Trustee at Ursinus College.
Previously, he served as the President, Chief Executive Officer & Director at Aevi Genomic Medicine, Inc., Chief Executive Officer & Director at Avalo Therapeutics, Inc., Chairman at SFN Group, Inc. (Massachusetts), Chairman at Clarient, Inc., Chairman at Laureate Biopharmaceutical Services, Inc., Independent Director at Vanda Pharmaceuticals, Inc., Independent Director at NuPathe, Inc., Director at Life Sciences Pennsylvania, President-Life Sciences Group at Safeguard Scientifics, Inc., Vice President-Global Clinical Operations at AstraZeneca PLC and Astra Merck, Inc., and President-Specialty Pharmaceuticals at Shire Plc.
He holds a graduate degree from Drexel University and an undergraduate degree from Ursinus College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 25/05/2023 | 18 798 ( 0.03% ) | 199 635 $ | 31/03/2024 | |
SAGE THERAPEUTICS, INC.
-.--% | 30/11/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Michael Cola
| Società | Posizione | Inizio |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Director/Board Member | 11/09/2014 |
| PHATHOM PHARMACEUTICALS, INC. | Chairman | 01/02/2022 |
| Ursinus College | Director/Board Member | - |
| The Boys & Girls Clubs of Philadelphia | Chairman | - |
Precedenti posizioni note di Michael Cola
| Società | Posizione | Fine |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Chief Executive Officer | 17/02/2022 |
| VANDA PHARMACEUTICALS INC. | Director/Board Member | 14/02/2020 |
| AEVI GENOMIC MEDICINE, INC. | Chief Executive Officer | 03/02/2020 |
Life Sciences Pennsylvania
 Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Director/Board Member | 01/01/2015 |
| NUPATHE INC | Chairman | 15/02/2011 |
Formazione di Michael Cola
| Drexel University | Graduate Degree |
| Ursinus College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 6 |
|---|---|
| SAFEGUARD SCIENTIFICS, INC. | Finance |
| ASTRAZENECA PLC | Health Technology |
| VANDA PHARMACEUTICALS INC. | Health Technology |
| AVALO THERAPEUTICS, INC. | Health Technology |
| SAGE THERAPEUTICS, INC. | Health Technology |
| PHATHOM PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 9 |
|---|---|
SFN Group, Inc. ( Massachusetts)
 SFN Group, Inc. ( Massachusetts) Personnel ServicesCommercial Services SFN Group, Inc. provides temporary personnel services to businesses professional and health care facilities. The company was founded in 1946 and is headquartered in Woburn, MA. | Commercial Services |
Clarient, Inc.
 Clarient, Inc. Medical/Nursing ServicesHealth Services Clarient, Inc. provides cancer diagnostic testing services. It offers oncology diagnostic testing services to community pathologists, oncologists, biopharmaceutical companies, and researchers. The company was founded in 1993 and is headquartered in Aliso Viejo, CA. | Health Services |
Shire Plc /Old/
 Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Commercial Services |
NuPathe, Inc.
 NuPathe, Inc. Medical SpecialtiesHealth Technology NuPathe, Inc. develops pharmaceutical and therapeutic products. It focuses on the development and commercialization of branded therapeutics for diseases of central nervous system, including neurological and psychiatric disorders. The company was founded by Terri B. Sebree and Jane Holmes Hollingsworth in 2005 and is headquartered in Malvern, PA. | Health Technology |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a private company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Health Technology |
Laureate Biopharmaceutical Services, Inc.
 Laureate Biopharmaceutical Services, Inc. Pharmaceuticals: MajorHealth Technology Laureate Biopharmaceutical Services, Inc. provides biopharmaceutical development and protein production services. It offers product development and manufacturing services from cell line optimization and process design to development of full-scale cGMP protein production, purification and aseptic filling, in addition to corresponding testing, validation, analytical and regulatory support. The firm's focus is on mammalian cell based monoclonal antibody and recombinant protein production for clinical and modest commercial supply. The company was founded in 1981 and is headquartered in Princeton, NJ. | Health Technology |
Aevi Genomic Medicine, Inc.
 Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engaged in the discovery of treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA. | Health Technology |
Life Sciences Pennsylvania
Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Commercial Services |
| The Boys & Girls Clubs of Philadelphia |
- Borsa valori
- Insiders
- Michael Cola
